171 related articles for article (PubMed ID: 22149608)
21. Variable presentation of neurological melioidosis in Northeast Thailand.
Limmathurotsakul D; Chaowagul W; Wongsrikaew P; Narmwong A; Day NP; Peacock SJ
Am J Trop Med Hyg; 2007 Jul; 77(1):118-20. PubMed ID: 17620641
[TBL] [Abstract][Full Text] [Related]
22. Melioidotic osteomyelitis treated with antibiotic-calcium hydroxyapatite composite: case report with four-year follow-up.
Ng WM; Kwan MK; Merican AM
Singapore Med J; 2006 Jan; 47(1):71-4. PubMed ID: 16397726
[TBL] [Abstract][Full Text] [Related]
23. [Melioidosis in a Danish tourist returning from North-eastern Thailand].
Leth S; Wang M; Deutch S
Ugeskr Laeger; 2014 Jun; 176(12):. PubMed ID: 25096943
[TBL] [Abstract][Full Text] [Related]
24. Combination antimicrobial therapy of acute Burkholderia pseudomallei infection in a mouse model.
Ulett GC; Norton RE; Hirst RG
Pathology; 1999 Aug; 31(3):264-7. PubMed ID: 10503275
[TBL] [Abstract][Full Text] [Related]
25. [In vitro antibiotic susceptibility compliance with efficacy of chemotherapy in infections due to pathogenic Burkholderias].
Iliukhin VI; Senina TV; Trushkina MN; Shubnikova EV; Antonov IuV; Andropova NV
Antibiot Khimioter; 2009; 54(7-8):19-23. PubMed ID: 20201399
[TBL] [Abstract][Full Text] [Related]
26. Gamma interferon supplementation for melioidosis.
Koh GC; Limmathurotsakul D
Antimicrob Agents Chemother; 2010 Oct; 54(10):4520; author reply 4520-1. PubMed ID: 20852188
[No Abstract] [Full Text] [Related]
27. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
Schweizer HP
Future Microbiol; 2012 Dec; 7(12):1389-99. PubMed ID: 23231488
[TBL] [Abstract][Full Text] [Related]
28. Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
Sarovich DS; Price EP; Von Schulze AT; Cook JM; Mayo M; Watson LM; Richardson L; Seymour ML; Tuanyok A; Engelthaler DM; Pearson T; Peacock SJ; Currie BJ; Keim P; Wagner DM
PLoS One; 2012; 7(2):e30789. PubMed ID: 22363490
[TBL] [Abstract][Full Text] [Related]
29. Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei.
LaRosa SP; Opal SM; Utterback B; Yan SC; Helterbrand J; Simpson AJ; Chaowagul W; White NJ; Fisher CJ
Int J Infect Dis; 2006 Jan; 10(1):25-31. PubMed ID: 16290015
[TBL] [Abstract][Full Text] [Related]
30. Isolated liver abscesses in melioidosis.
Mukhopadhya A; Balaji V; Jesudason MV; Amte A; Jeyamani R; Kurian G
Indian J Med Microbiol; 2007 Apr; 25(2):150-1. PubMed ID: 17582188
[TBL] [Abstract][Full Text] [Related]
31. Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters.
Huffam S; Jacups SP; Kittler P; Currie BJ
Trop Med Int Health; 2004 Jun; 9(6):715-7. PubMed ID: 15189462
[TBL] [Abstract][Full Text] [Related]
32. Burkholderia pseudomallei - a rare cause for septic arthritis.
Karuppal R; Marthya A; Justus S; Kumaran CM; Padinjareyil G
Joint Bone Spine; 2007 Dec; 74(6):659-60. PubMed ID: 17913555
[No Abstract] [Full Text] [Related]
33. Use of a low-dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei.
Panomket P; Chetchotisakd P; Sermswan RW; Pannengpetch P; Wongratanacheewin S
Ann Trop Med Parasitol; 2009 Oct; 103(7):635-46. PubMed ID: 19825285
[TBL] [Abstract][Full Text] [Related]
34. Melioidosis presenting as sepsis syndrome: a case report.
Redondo MC; Gómez M; Landaeta ME; Ríos H; Khalil R; Guevara RN; Palavecino S; Figuera M; Caldera J; Rivera R; Calvo A; Vitelli J; Morón M; Nuñez MJ
Int J Infect Dis; 2011 Mar; 15(3):e217-8. PubMed ID: 21195650
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous melioidosis.
Teo L; Tay YK; Mancer KJ
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1322-4. PubMed ID: 17062053
[TBL] [Abstract][Full Text] [Related]
36. Multiple visceral abscess in a case of melioidosis.
Navaneethan U; Ramesh Kumar AC; Ravi G
Indian J Med Sci; 2006 Feb; 60(2):68-70. PubMed ID: 16505577
[No Abstract] [Full Text] [Related]
37. Recent advances in the treatment of severe melioidosis.
Chaowagul W
Acta Trop; 2000 Feb; 74(2-3):133-7. PubMed ID: 10674641
[TBL] [Abstract][Full Text] [Related]
38. Formulation and Characterization of Nanocluster Ceftazidime for the Treatment of Acute Pulmonary Melioidosis.
Ruiz SI; El-Gendy N; Bowen LE; Berkland C; Bailey MM
J Pharm Sci; 2016 Nov; 105(11):3399-3408. PubMed ID: 27639659
[TBL] [Abstract][Full Text] [Related]
39. Differential antibiotic-induced endotoxin release in severe melioidosis.
Simpson AJ; Opal SM; Angus BJ; Prins JM; Palardy JE; Parejo NA; Chaowagul W; White NJ
J Infect Dis; 2000 Mar; 181(3):1014-9. PubMed ID: 10720525
[TBL] [Abstract][Full Text] [Related]
40. Burkholderia pseudomallei endophthalmitis.
Chen KJ; Sun MH; Hou CH; Sun CC; Chen TL
J Clin Microbiol; 2007 Dec; 45(12):4073-4. PubMed ID: 17913931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
